These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37957561)

  • 61. Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.
    Emans ME; van der Putten K; Velthuis BK; de Vries JJ; Cramer MJ; America YG; Hillege HL; Meiss L; Doevendans PA; Braam B; Gaillard CA
    BMC Cardiovasc Disord; 2012 Sep; 12():76. PubMed ID: 22989293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population.
    Lim CC; Teo BW; Ong PG; Cheung CY; Lim SC; Chow KY; Meng CC; Lee J; Tai ES; Wong TY; Sabanayagam C
    Eur J Prev Cardiol; 2015 Aug; 22(8):1018-26. PubMed ID: 24857889
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
    Wanner C; Lachin JM; Inzucchi SE; Fitchett D; Mattheus M; George J; Woerle HJ; Broedl UC; von Eynatten M; Zinman B;
    Circulation; 2018 Jan; 137(2):119-129. PubMed ID: 28904068
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey.
    Zdrojewski Ł; Zdrojewski T; Rutkowski M; Bandosz P; Król E; Wyrzykowski B; Rutkowski B
    Nephrol Dial Transplant; 2016 Mar; 31(3):433-9. PubMed ID: 26560810
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial.
    Filippatos G; Pitt B; Agarwal R; Farmakis D; Ruilope LM; Rossing P; Bauersachs J; Mentz RJ; Kolkhof P; Scott C; Joseph A; Bakris GL; Anker SD;
    Eur J Heart Fail; 2022 Jun; 24(6):996-1005. PubMed ID: 35239204
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Light wine consumption is associated with a lower odd for cardiovascular disease in chronic kidney disease.
    Jespersen T; Kruse N; Mehta T; Kuwabara M; Noureddine L; Jalal D
    Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1133-1139. PubMed ID: 30143406
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study.
    Lawson CA; Testani JM; Mamas M; Damman K; Jones PW; Teece L; Kadam UT
    Int J Cardiol; 2018 Sep; 267():120-127. PubMed ID: 29957251
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis.
    Ponte B; Pruijm M; Marques-Vidal P; Martin PY; Burnier M; Paccaud F; Waeber G; Vollenweider P; Bochud M
    Nephrol Dial Transplant; 2013 Sep; 28(9):2329-39. PubMed ID: 23825103
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
    Dal Canto E; Elders PJM; van der Heijden AA; van Ballegooijen AJ; Lissenberg-Witte BI; Rutters F; Beulens JWJ
    Diabetologia; 2023 Mar; 66(3):482-494. PubMed ID: 36347992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States.
    Lin Y; Shao H; Fonseca V; Anderson AH; Batuman V; Shi L
    Diabetes Obes Metab; 2023 Oct; 25(10):2862-2868. PubMed ID: 37334525
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes.
    Filippatos G; Bakris GL; Pitt B; Agarwal R; Rossing P; Ruilope LM; Butler J; Lam CSP; Kolkhof P; Roberts L; Tasto C; Joseph A; Anker SD;
    J Am Coll Cardiol; 2021 Jul; 78(2):142-152. PubMed ID: 34015478
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain.
    Escobar C; Aranda U; Palacios B; Capel M; Sicras A; Sicras A; Hormigo A; Alcázar R; Manito N; Botana M
    Nefrologia (Engl Ed); 2021; 41(6):670-688. PubMed ID: 36165157
    [TBL] [Abstract][Full Text] [Related]  

  • 75. AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D).
    Chu L; Bhogal SK; Lin P; Steele A; Fuller M; Ciaccia A; Abitbol A
    Can J Diabetes; 2022 Jul; 46(5):464-472. PubMed ID: 35739044
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence and awareness of chronic kidney disease among adult diabetic outpatients in Northeast Ethiopia.
    Fiseha T; Tamir Z
    BMC Nephrol; 2020 Apr; 21(1):129. PubMed ID: 32293323
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence and related risk factors of chronic kidney disease among adults in Luxembourg: evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) study.
    Alkerwi A; Sauvageot N; El Bahi I; Delagardelle C; Beissel J; Noppe S; Roderick PJ; Mindell JS; Stranges S
    BMC Nephrol; 2017 Dec; 18(1):358. PubMed ID: 29221436
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.
    Ducluzeau PH; Fauchier G; Herbert J; Semaan C; Halimi JM; Angoulvant D; Fauchier L
    Diabetes Metab; 2023 May; 49(3):101429. PubMed ID: 36736892
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of four equations for estimation of glomerular filtration rate in predicting cardiovascular events and subclinical vascular disease in patients with type-2 diabetes.
    Sow MA; Magne J; Toure F; Teissier MP; Aboyans V
    Prim Care Diabetes; 2022 Feb; 16(1):196-201. PubMed ID: 34996689
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.
    Murea M; Hsu FC; Cox AJ; Hugenschmidt CE; Xu J; Adams JN; Raffield LM; Whitlow CT; Maldjian JA; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2015 Aug; 30(8):1322-9. PubMed ID: 25722384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.